| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abatacept for IgG4-related disease: therapeutic prospects according to disease immunophenotype
|
Peng, Yu
|
|
|
4 |
2 |
p. e75-e76
|
article
|
| 2 |
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study
|
Matza, Mark A
|
|
|
4 |
2 |
p. e105-e112
|
article
|
| 3 |
Allogeneic mesenchymal stromal cell transplantation for systemic sclerosis
|
Volkmann, Elizabeth R
|
|
|
4 |
2 |
p. e74-e75
|
article
|
| 4 |
David Liew: where communication meets medicine
|
Burton, Adrian
|
|
|
4 |
2 |
p. e90
|
article
|
| 5 |
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
|
Gao, Xing-Su
|
|
|
4 |
2 |
p. e77-e78
|
article
|
| 6 |
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
|
Shenoy, Padmanabha
|
|
|
4 |
2 |
p. e80-e82
|
article
|
| 7 |
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
|
Aikawa, Nadia E
|
|
|
4 |
2 |
p. e113-e124
|
article
|
| 8 |
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
|
Barbhaiya, Medha
|
|
|
4 |
2 |
p. e85-e87
|
article
|
| 9 |
Industry involvement in rheumatology consensus-based recommendations: a systematic review
|
Feterman Jimenez, Dominique
|
|
|
4 |
2 |
p. e145-e152
|
article
|
| 10 |
Mental health before and during the pandemic in people with systemic sclerosis
|
Henry, Richard S
|
|
|
4 |
2 |
p. e82-e85
|
article
|
| 11 |
Novel COVID-19 therapies: the road ahead for rheumatology
|
The Lancet Rheumatology,
|
|
|
4 |
2 |
p. e73
|
article
|
| 12 |
Predicting the risk of needing a total knee arthroplasty
|
Clement, Nick D
|
|
|
4 |
2 |
p. e78-e79
|
article
|
| 13 |
Prediction models for the risk of total knee replacement: development and validation using data from multicentre cohort studies
|
Liu, Qiang
|
|
|
4 |
2 |
p. e125-e134
|
article
|
| 14 |
Research in Brief
|
Thorley, Jennifer
|
|
|
4 |
2 |
p. e88
|
article
|
| 15 |
Rheumatoid arthritis, then and now
|
Michell, Bob
|
|
|
4 |
2 |
p. e89
|
article
|
| 16 |
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
|
Farge, Dominique
|
|
|
4 |
2 |
p. e91-e104
|
article
|
| 17 |
Therapeutic implications of ongoing alveolar viral replication in COVID-19
|
McGonagle, Dennis
|
|
|
4 |
2 |
p. e135-e144
|
article
|
Journal description